StockData
Ocular Therapeutix, Inc logo

Ocular Therapeutix, Inc (OCUL) stock

OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3011% above fair value
$5.94−0.08 (-1.33%)

Close on Nov 18, 2026Market cap $1.30BP/E –Yield –

Ocular Therapeutix pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Ocular Therapeutix

Ocular Therapeutix has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Ocular Therapeutix figures

See a number that looks wrong?